What is X4 Pharmaceuticals, Inc. Common Stock's Market Cap?

X4 Pharmaceuticals, Inc. Common Stock's Market Cap is $347.5M, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's Enterprise Value?

X4 Pharmaceuticals, Inc. Common Stock's Enterprise Value is $227.4M, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's Price / Sales?

X4 Pharmaceuticals, Inc. Common Stock's Price / Sales is 21.9×, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's EV / Revenue?

X4 Pharmaceuticals, Inc. Common Stock's EV / Revenue is 14.4×, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

X4 Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

X4 Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $15.8M, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

X4 Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$90.1M, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's EBITDA?

X4 Pharmaceuticals, Inc. Common Stock's EBITDA is -$86.2M, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

X4 Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.91, based on as-reported figures from SEC (XBRL) filings.

What is X4 Pharmaceuticals, Inc. Common Stock's EBITDA Margin?

X4 Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -544.2%, based on as-reported figures from SEC (XBRL) filings.

X4 Pharmaceuticals, Inc. Common Stock (XFOR) Financial Statements

X4 Pharmaceuticals, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001TCY1B7

XNAS · usd

3.51▼ 0.54 (-13.24%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close4.04

Day's Range3.19 – 4.13

52-Week Range2.80 – 4.83

Volume2.3M

Avg Volume679.1K

Share Statistics

Shares Outstanding

Employees45

ExchangeXNAS

Listed2017-11-16

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about X4 Pharmaceuticals, Inc. Common Stock (XFOR)

What is X4 Pharmaceuticals, Inc. Common Stock's Market Cap?: X4 Pharmaceuticals, Inc. Common Stock's Market Cap is $347.5M, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's Enterprise Value?: X4 Pharmaceuticals, Inc. Common Stock's Enterprise Value is $227.4M, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's Price / Sales?: X4 Pharmaceuticals, Inc. Common Stock's Price / Sales is 21.9×, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's EV / Revenue?: X4 Pharmaceuticals, Inc. Common Stock's EV / Revenue is 14.4×, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: X4 Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: X4 Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $15.8M, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: X4 Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$90.1M, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's EBITDA?: X4 Pharmaceuticals, Inc. Common Stock's EBITDA is -$86.2M, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: X4 Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.91, based on as-reported figures from SEC (XBRL) filings.
What is X4 Pharmaceuticals, Inc. Common Stock's EBITDA Margin?: X4 Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -544.2%, based on as-reported figures from SEC (XBRL) filings.